Science and Technology Production
Congress
Authorship
Gastón Siless
;
CABRERA, GABRIELA MYRIAM
Date
2014
Publishing House and Editing Place
NC
ISSN
978-2-8399-1514-4
Summary
Information provided by the agent in
SIGEVA
Histone deacetylase inhibitors (HDACIs) are a class of anti-cancer drugs which act as epigenetic modifiers. The HDAC family of enzymes consists of 18 known members divided into four classes, three of which are metalloenzymes that require a divalent metal ion for substrate binding and catalysis. Different classes of HDACIs are known, some of which are hydroxamic acids that chelate active Zn2+ in a bidentate manner. Since the mode of action of these compounds is related to its binding capacity of...
Histone deacetylase inhibitors (HDACIs) are a class of anti-cancer drugs which act as epigenetic modifiers. The HDAC family of enzymes consists of 18 known members divided into four classes, three of which are metalloenzymes that require a divalent metal ion for substrate binding and catalysis. Different classes of HDACIs are known, some of which are hydroxamic acids that chelate active Zn2+ in a bidentate manner. Since the mode of action of these compounds is related to its binding capacity of Zn2+, and they are known to chelate other metals such as Co, Cu or Ni, the goal of this study was the analysis by Electrospray of the complexes obtained from HDACIs in the presence of Zn2+ and other metals and compare their differences.
Show more
Show less
Key Words
HDACmetal complexationESI